Anaveon Revenue and Competitors
Estimated Revenue & Valuation
- Anaveon's estimated annual revenue is currently $5.1M per year.
- Anaveon's estimated revenue per employee is $155,000
Employee Data
- Anaveon has 33 Employees.
- Anaveon grew their employee count by -13% last year.
Anaveon's People
| Name | Title | Email/Phone |
|---|
Anaveon Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Anaveon?
A start up based in Switzerland that develops biologics to modulate the functions of cytokines and provide substantial therapeutic benefits to cancer patients.
keywords:N/A
N/A
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Anaveon News
2022-04-13 - Syncona's investee Anaveon receives good trial data
Anaveon is a Basel, Switzerland-based clinical-stage immuno-oncology firm. It is currently developing ANV419, which is an immunotherapy for...
2022-04-06 - Anaveon presents compelling data from the Phase I/II study of ...
BASEL, Switzerland, April 08, 2022 (GLOBE NEWSWIRE) -- Anaveon, a clinical-stage immuno-oncology company, today announced first clinical...
Other Companies in Basel
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5.1M | 33 | 38% | N/A |
#2 | $5.3M | 34 | 17% | N/A |
#3 | $3.9M | 34 | 31% | N/A |
#4 | $5.4M | 35 | 9% | N/A |
#5 | $7.3M | 36 | 6% | N/A |